- is an
American company based in Reston, Virginia, that
develops nanopharmaceuticals and
provides DNA
phenotyping services for law
enforcement organizations...
- PMID 20108971. "Cerulean
Raises $24M to
Progress Clinical Development of
Nanopharmaceuticals". 15 Nov 2010.
Yamazaki Y,
Kitajima M,
Arita M,
Takayama H, Sudo...
-
Cardiovascular Medicine:
Trends in
Myocardial Infarction Therapy",
Nanopharmaceuticals in
Regenerative Medicine (1 ed.), Boca Raton: CRC Press, pp. 303–327...
- Roointan, Amir; Karimi, Mahdi; Hamblin,
Michael R (January 2019). "
Nanopharmaceuticals and
nanomedicines currently on the market:
challenges and opportunities"...
- the
product was
transferred to Nanoshift, LLC.
Nanoshift LLC and
Nanopharmaceutics, Inc.
continue to
support clinical studies with the NCI. Kowol, Christian...
- Architecture,
Civil Engineering and
Industrial Management Engineering Nanopharmaceutical Sciences Nagoya Institute of
Technology and
University of Wollongong...
-
Jointly Establishing the World's
First Research Professorship for
Nanopharmaceutical and
Regulatory Science". Businesswire. 2019-05-26.
Retrieved 2022-06-28...
- companies.
Sasisekharan co-founded
Cerulean in 2006 to
leverage nanopharmaceuticals to
target tumors with
highly potent chemotherapeutics. Sasisekharan...
- was
transferred to Nanoshift, LLC.
Nanoshift LLC and
Nanopharmaceutics, Inc. (www.
nanopharmaceutics.com)
continue to
support clinical studies. It has been...
- "Imaging of
Guerin Carcinoma During Magnetic Nanotherapy".
Journal of
Nanopharmaceutics and Drug Delivery. 2: 58–68. doi:10.1166/jnd.2014.1044. Orel, Valerii...
